| scholarly article | Q13442814 |
| P2093 | author name string | Jun Lou | |
| Huang Huang | |||
| Xiao-Yan Chu | |||
| Li-Xian Xu | |||
| Li-Qun Wang | |||
| Zhi-Min Wu | |||
| Ou-Ping Huang | |||
| Xin-Min Yang | |||
| Yuan-Ting Chen | |||
| P2860 | cites work | Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis. | Q39214999 |
| Mutational analysis of the RAS/RAF/MEK/ERK signaling pathway in 260 Han Chinese patients with cervical carcinoma | Q40092876 | ||
| Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens. | Q40319552 | ||
| Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity. | Q40479849 | ||
| Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. | Q44435863 | ||
| Molecular mechanism of estrogen-estrogen receptor signaling | Q47140933 | ||
| Cancer statistics, 2018. | Q47191906 | ||
| Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines. | Q47563209 | ||
| The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment. | Q49836600 | ||
| Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils. | Q50912572 | ||
| MutationTaster2: mutation prediction for the deep-sequencing age. | Q52877992 | ||
| A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions | Q74181062 | ||
| Pap tests in the diagnosis of cervical cancer: Help or hinder? | Q88719977 | ||
| Estrogen receptor (ESR1) mutation in bone metastases from breast cancer | Q88752161 | ||
| An integrated map of genetic variation from 1,092 human genomes | Q22122153 | ||
| The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study | Q25257794 | ||
| MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0 | Q26778434 | ||
| Analysis of protein-coding genetic variation in 60,706 humans | Q26831376 | ||
| Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor | Q27637534 | ||
| Activating ESR1 mutations in hormone-resistant metastatic breast cancer | Q27852630 | ||
| ESR1 ligand-binding domain mutations in hormone-resistant breast cancer | Q27852637 | ||
| A method and server for predicting damaging missense mutations | Q27860835 | ||
| The consensus coding sequences of human breast and colorectal cancers | Q27861035 | ||
| Defining and searching for structural motifs using DeepView/Swiss-PdbViewer | Q30419546 | ||
| Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels | Q30534669 | ||
| Sequence analysis of mutations and translocations across breast cancer subtypes | Q34032470 | ||
| Landscape of genomic alterations in cervical carcinomas | Q34169464 | ||
| Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study | Q35030216 | ||
| Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer | Q35794355 | ||
| Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling | Q35796047 | ||
| Estrogen receptor-beta and breast cancer: translating biology into clinical practice | Q35973424 | ||
| Genetic profiles of cervical tumors by high-throughput sequencing for personalized medical care. | Q36201454 | ||
| Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis. | Q36233937 | ||
| Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients | Q36288939 | ||
| Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels | Q36355909 | ||
| Endocrine resistance in breast cancer--An overview and update | Q36386322 | ||
| Association of estrogen receptor-α A908G (K303R) mutation with breast cancer risk | Q36449789 | ||
| Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients | Q36642923 | ||
| Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer. | Q36930858 | ||
| Integrated genomic and molecular characterization of cervical cancer | Q37706407 | ||
| Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing. | Q38913843 | ||
| The role and impact of estrogens and xenoestrogen on the development of cervical cancer | Q39013498 | ||
| Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists. | Q39093601 | ||
| P433 | issue | 3 | |
| P921 | main subject | cervix uterine cancer | Q160105 |
| P304 | page(s) | 2771-2776 | |
| P577 | publication date | 2019-07-15 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Estrogen receptor 1 mutations in 260 cervical cancer samples from Chinese patients | |
| P478 | volume | 18 |
Search more.